Hutchin Hill Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,710
Closed -$628K 909
2017
Q2
$628K Sell
19,710
-105,611
-84% -$3.33M 0.02% 628
2017
Q1
$4.07M Buy
125,321
+71,145
+131% +$2.24M 0.11% 203
2016
Q4
$1.67M Buy
54,176
+31,620
+140% +$965K 0.06% 356
2016
Q3
$725K Buy
22,556
+15,600
+224% +$522K 0.01% 426
2016
Q2
$232K Sell
6,956
-140,604
-95% -$4.49M 0.01% 469
2016
Q1
$4.15M Sell
147,560
-484,840
-77% -$13.8M 0.12% 216
2015
Q4
$19.4M Buy
+632,400
New +$19.9M 0.48% 39
2015
Q2
Sell
-125,004
Closed -$4.13M 777
2015
Q1
$4.13M Buy
+125,004
New +$3.97M 0.11% 199
2014
Q4
Sell
-135,650
Closed -$3.81M 667
2014
Q3
$3.81M Buy
135,650
+93,068
+219% +$2.61M 0.14% 168
2014
Q2
$1.2M Sell
42,582
-27,298
-39% -$778K 0.05% 314
2014
Q1
$2.13M Buy
69,880
+3,689
+6% +$110K 0.11% 174
2013
Q4
$1.92M Buy
66,191
+46,587
+238% +$1.36M 0.13% 154
2013
Q3
$534K Buy
+19,604
New +$533K 0.05% 323

Other funds holding PFE

Hutchin Hill Capital's PFE Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Pfizer (PFE) in Q3 2017, closing a stake of 19,710 shares — an estimated $628K sold.

Hutchin Hill Capital first reported a position in PFE in Q3 2013 and held it in 13 quarters. The position peaked at $19.4M in Q4 2015. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 19,710 Pfizer shares in Q3 2017, an estimated $628K.
  • Hutchin Hill Capital first reported a position in Pfizer in Q3 2013 and held it in 13 quarters.
  • Hutchin Hill Capital's Pfizer position peaked at $19.4M in Q4 2015.
  • 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.